Citrate functionalized Mn(3)O(4) in nanotherapy of hepatic fibrosis by oral administration

AIM: To test the potential of orally administered citrate functionalized Mn(3)O(4) nanoparticles (C-Mn(3)O(4) NPs) as a therapeutic agent against hepatic fibrosis and associated chronic liver diseases. MATERIALS & METHODS: C-Mn(3)O(4) NPs were synthesized and the pH dependent antioxidant mechani...

Descripción completa

Detalles Bibliográficos
Autores principales: Adhikari, Aniruddha, Polley, Nabarun, Darbar, Soumendra, Bagchi, Damayanti, Pal, Samir Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242211/
https://www.ncbi.nlm.nih.gov/pubmed/28116129
http://dx.doi.org/10.4155/fsoa-2016-0029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242211/
https://www.ncbi.nlm.nih.gov/pubmed/28116129
http://dx.doi.org/10.4155/fsoa-2016-0029

Ejemplares similares